Positron emission tomography (PET) imaging with radiotracers that target translocator protein 18 kDa (TSPO) has become a popular approach to assess putative neuroinflammatory processes and associated microglia activation in psychotic illnesses. It remains unclear, however, whether TSPO imaging can accurately capture low-grade inflammatory processes such as those present in schizophrenia and related disorders. Therefore, we evaluated the validity of TSPO as a disease-relevant marker of inflammation using a translational approach, which combined neurodevelopmental and neurodegenerative mouse models with PET imaging in patients with recent-onset schizophrenia and matched controls. Using an infection-mediated neurodevelopmental mouse model, we show that schizophrenia-relevant behavioral abnormalities and increased inflammatory cytokine expression are associated with reduced prefrontal TSPO levels. On the other hand, TSPO was markedly upregulated in a mouse model of acute neurodegeneration and reactive gliosis, which was induced by intrahippocampal injection of kainic acid. In both models, the changes in TSPO levels were not restricted to microglia but emerged in various cell types, including microglia, astrocytes and vascular endothelial cells. Human PET imaging using the second-generation TSPO radiotracer [
INTRODUCTION
Inflammatory theories in schizophrenia have gained increasing recognition and acceptance in recent years. [1] [2] [3] [4] The evidence supporting a role of altered inflammatory processes in the etiology and pathophysiology of schizophrenia involves early-life exposure to infectious pathogens or inflammatory stimuli, 5, 6 increased expression of cytokines and other mediators of inflammation in the adult central nervous system (CNS) and periphery, [7] [8] [9] [10] [11] as well as signs of glial anomalies. [11] [12] [13] Noticeable inflammatory abnormalities, however, may only be present in a subgroup of people with schizophrenia and may predict poorer clinical outcomes and treatment responses. 11, [14] [15] [16] [17] Additional support for inflammatory theories in schizophrenia stem from clinical trials showing superior beneficial treatment effects in a subset of patients when standard antipsychotic drugs are coadministered with anti-inflammatory compounds, as compared with treatment outcomes using antipsychotic drugs alone. [18] [19] [20] [21] Positron emission tomography (PET) using radiolabeled ligands selective for the 18-kDa translocator protein (TSPO) is one of the most widely used in vivo techniques for the assessment of inflammatory abnormalities along the clinical course of schizphrenia. [22] [23] [24] [25] [26] [27] Previously known as the peripheral benzodiazepine receptor, TSPO is a transmembrane protein that is located mainly in the outer mitochondrial membrane. [27] [28] [29] A wide variety of biological functions have been associated with TSPO, including regulation of cholesterol transport and synthesis of steroid hormones, mitochondrial respiration and ATP production, cell proliferation and apoptosis, and immunomodulation. [28] [29] [30] Even though some of the functions of TSPO remain ill-defined, 30 radiotracers against TSPO are widely used to detect putative neuroinflammatory processes and associated microglia activation in schizophrenia. [24] [25] [26] [27] The underlying rationale is that TSPO binding increases in response to marked inflammatory stimuli such as acute endotoxemia, 31 which in turn correlates to some 1 Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zurich, Switzerland; extent with changes in the activation status of microglia. 32 Furthermore, TSPO is robustly increased in neuropathologies that are characterized by marked signs of neuroinflammation, including blood-brain barrier rupture, neurodegeneration and reactive gliosis. [33] [34] [35] Whereas initial studies using first-generation TSPO radiotracers such as [ 11 C]PK11195 have reported increased TSPO binding in patients with schizophrenia, 36 ,37 studies using second-generation TSPO ligands remain equivocal and provided both positive 38 and negative [39] [40] [41] [42] [43] reports. Compared with first-generation TSPO radiotracers, second-generation radiotracers are characterized by increased brain permeability and lower off-target binding such as plasma protein binding, which in turn enhances signal-to-noise ratios. 26, 44, 45 Notably, a recent within-subject study combining second-generation TSPO PET imaging with peripheral and central cytokine profiling found no clear relationship between low-grade inflammation and TSPO binding in recent-onset schizophrenia. 41 Therefore, it remains unclear whether subtle changes in inflammatory processes, such as those present in schizophrenia, can be accurately captured by TSPO PET imaging.
To advance our understanding of the putative relationship between TSPO and inflammatory alterations in schizophrenia, we implemented a translational approach that combined investigations in a disease-relevant animal model with imaging studies in patients with recent-onset schizophrenia. We used a wellestablished neurodevelopmental mouse model that has been developed based on the epidemiological evidence linking maternal immune activation (MIA) with increased risk of schizophrenia in the offspring. 5, 6, 46 In this model, pregnant mice are treated with the viral mimic poly(I:C) (POL; = polyriboinosinicpolyribocytidylic acid), which induces a cytokine-associated viral-like acute-phase response in maternal and fetal compartments. 47, 48 Prenatal POL treatment in mice leads to multiple behavioral, cognitive and neuronal disturbances in the adult offspring, many of which are implicated in schizophrenia and related disorders. [46] [47] [48] [49] [50] Prenatal POL exposure has also been shown to induce persistent signs of low-grade inflammation in the CNS. 51, 52 The MIA model thus offers a unique opportunity to identify possible changes in TSPO expression in a neurodevelopmental animal model with relevance to schizophrenia, and to examine the putative relationship between TSPO and low-grade inflammatory processes. We further compared the MIA model with a mouse model of acute neuronal injury induced by intrahippocampal injection of kainic acid (KA), which is characterized by severe reactive gliosis. [53] [54] [55] [56] [57] The KA model thus served as a positive control (CON) for the hypothesis that TSPO expression is increased in the event of increased microglia activation. [24] [25] [26] [27] Based on the findings from the MIA model, we then analyzed PET TSPO binding in selected brain regions of patients with recent-onset schizophrenia and matched CONs. Our human cohort was previously characterized in terms of peripheral and central inflammation, which confirmed a significant elevation of inflammatory cytokines in plasma and cerebrospinal fluid in schizophrenia patients. 41 Thus, we believe the present study provides the first translational evaluation of TSPO as a marker of aberrant inflammatory processes in the context of schizophrenia and related neurodevelopmental disorders.
MATERIALS AND METHODS Animals
All mouse models (see below) were performed using C57Bl6/N mice (Charles Rivers, Sulzfeld, Germany). All procedures involving animal experimentation had been previously approved by the Cantonal Veterinarian's Office of Zurich, and all efforts were made to minimize the number of animals used and their suffering.
MIA model
Female mice were subjected to a timed mating procedure as established previously. 48, 50 Pregnant dams were subjected to either a single injection of POL (potassium salt; Sigma-Aldrich, Buchs, St Gallen, Switzerland) or vehicle on gestation day 9 (Supplementary Information). POL (5 mg kg − 1 ) was dissolved in sterile pyrogen-free 0.9% NaCl (vehicle) solution to yield a final concentration of 1 mg ml − 1 and was administered intravenously into the tail vein (Supplementary Information).
The allocation and housing of POL-exposed and CON offspring are described in the Supplementary Information. Three independent cohorts of CON and POL offspring were used, each stemming from multiple independent litters to avoid litter effects (Supplementary Information). Cohorts 1 and 2 were first subjected to behavioral testing to allow correlative analyses between behavioral and immunohistochemical readouts (see below). Offspring in cohort 3 were assigned to ex vivo TSPO ligand-binding studies and cytokine measurements (see below) without prior behavioral testing.
Behavioral testing in the MIA model Male and female POL and CON offspring were tested in paradigms of prepulse inhibition (PPI) of the acoustic startle reflex (cohort 1) and social interaction (cohort 2) to confirm the presence of selected schizophreniarelevant behavioral phenotypes. 50, [58] [59] [60] A detailed description of the test apparatuses and procedures is provided in the Supplementary Information. Behavioral testing was conducted when the offspring reached 12 weeks of age based on previous findings. 50, 52, 61, 62 KA injection model
The KA model followed procedures established and validated before. 54 As described in the Supplementary Information, KA was injected unilaterally into the CA1 region of the right dorsal hippocampus, and the animals (N = 8) were killed for immunohistochemical investigations of TSPO and glial markers 3 weeks post injection (Supplementary Information). The post-injection interval was selected based on previous studies showing marked reactive gliosis in response to KA injection at this interval. [54] [55] [56] [57] Immunohistochemistry in animal models CON and POL mice were perfused intracardially with 4% phosphatebuffered paraformaldehyde (PFA) solution containing 15% picric acid, followed by post-fixation in PFA, antigen retrieval and cryoprotection (Supplementary Information). Animals with intrahippocampal KA or vehicle injections were perfused intracardially with oxygenated artificial cerebrospinal fluid, followed by post-fixation in PFA and cryoprotection as previously described. 63 
Microscopy and optical densitometry in animal models
Images of IP-stained sections were acquired with a digital camera using bright-field illumination (Zeiss Axioskop, Zeiss, Jena, Germany), whereas images of triple IF-stained sections were acquired using confocal laser scanning microscopy (LSM-700; Zeiss; Supplementary Information). Quantification of total TSPO, CD68 and GFAP in IP-stained sections was achieved by means of optical densitometry using NIH ImageJ software (https:// imagej.nih.gov/ij/) (Supplementary Information) and was performed using male and female CON and POL offspring to reveal possible sex-dependent effects, and in adult males subjected to intrahippocampal KA injections. The total number of Iba + microglia cells was quantified in male CON and POL offspring using unbiased stereological estimations (Supplementary Information); and microglia cell morphology (cell soma size and number of primary branches) were assessed on IP-stained Iba1 sections according to methods established before 52 and described in the Supplementary Information.
For IF-stained sections, total TSPO intensity and TSPO intensity co-localized with microglia (Iba1 or CD68), astrocytes (GFAP) or vascular TSPO, inflammation and schizophrenia T Notter et al endothelial cells (Glut1) were measured and calculated on z-projected image stacks using a customized macro for the ImageJ software (Supplementary Information). Based on the lack of sex-dependent effects in the analyses of IP-stained sections, IF-stained sections in the MIA model were analyzed in male offspring only. Images were acquired on consecutive serial sections and analyzed in the medial prefrontal cortex (mPFC), CA1-CA3 regions (CA) of the hippocampus and dentate gyrus. These brain regions were selected based on their relevance to schizophrenia. 64, 65 TSPO autoradiography in the MIA model Ex vivo TSPO ligand-binding studies were performed in the mPFC of CON and POL offspring using autoradiography. 66 Animals (12 weeks of age; N = 9 per group) were killed by decapitation. Their brains were immediately removed on an ice-chilled plate, divided into left and right hemispheres, frozen with powdered dry ice, and stored at − 80°C until further processing. Autoradiography was performed on the right brain hemisphere, whereas the left hemisphere was used for the quantification of inflammatory cytokines in the mPFC (see below). TSPO ligand binding was assessed using the first-generation radiotracer [ The former was selected because it represents the prototypical first-generation TSPO radiotracer, 26, 28 whereas the latter was chosen to match the TSPO PET imaging study in patients with recent-onset schizophrenia and CON subjects (see below).
Quantification of inflammatory cytokines in the MIA model
Protein levels of interleukin (IL)-1β, IL-5, IL-6, IL-10, tumor necrosis factor-α and interferon-γ were quantified in plasma and in the left-hemisphere mPFC of CON and POL offspring (N = 9 per group) using a customized Meso-Scale Discovery V-Plex electrochemiluminescence assay for mice, which allows ultralow detection of multiple cytokines. 67 The quantification of cytokines followed procedures validated before 52 and is described in the Supplementary Information.
Human subjects
The PET imaging data set included in this study consisted of data from 12 patients with recent onset of schizophrenia and 14 healthy CON subjects (Supplementary Information). The cohort used here is identical to the patients and CONs with PET imaging data included in a recent study. 41 The average duration of disease among patients was 2.1 ± 1.4 years. Antipsychotic medication use by the patients was reported in chlorpromazine equivalents and ranged from 0 to 1119 (mean 494.8 ± 382.0). The PET imaging study was approved by the Johns Hopkins Institutional Review Board, and all participants provided written informed consent.
PET in patients with schizophrenia and CONs PET imaging was conducted using the second-generation TSPO radiotracer [ 11 C]DPA-713. [ 11 C]DPA-713 was selected because it is characterized by an increased signal-to-noise ratio as compared with the first-generation radiotracer [
11 C]PK11195. 44, 45, 68 Like other second-generation TSPO radiotracers, [ 11 C]DPA-713 differentially binds to TSPO depending on the singlenucleotide polymorphism (SNP), rs6971, in exon 4 of the TSPO gene, which results in an alanine to threonine substitution. 69, 70 Based on genotyping of the rs6971 SNP, each individual undergoing a [ 11 C]DPA-713 PET scan can therefore be grouped as either high (C/C genotype)-, mixed (C/T genotype)-or low (T/T genotype)-affinity binders. 70 As fully described before, 41 each individual included in our clinical setting was genotyped with respect to the rs6971 SNP. Among the 26 participants, genotyping of the rs6971 polymorphism within the TSPO gene revealed 17 individuals with C/C genotype and 9 participants with C/T genotype. 41 PET images were acquired on High Resolution Research Tomograph scanner (Siemens Healthcare, Knoxville, TN, USA) after a bolus injection of 684.0 ± 53.1 MBq of [
11 C]DPA-713 and were processed and analyzed as described in the Supplementary Information. Based on the findings provided by the MIA model, [ 11 C]DPA-713 binding was analyzed in the middle frontal gyrus (MFG). The MFG spans a substantial part of the human dorsolateral prefrontal cortex, 71, 72 which in turn is structurally and functionally related to the mPFC in rodents. 73, 74 The primary PET-based regional binding outcome was total distribution volume (V T ), 75 which was calculated using the Logan method (Supplementary Information).
Statistical analysis
All data met the assumptions of normal distribution and equality of variance. All mouse model data were analyzed using analysis of variance (ANOVA), multivariate analysis of variance, independent Student's t-tests (two-tailed) and Pearson's product moment correlations as described in the Supplementary Information. These analyses were conducted using SPSS Statistics (version 22.0, IBM, Armonk, NY, USA) and Prism (version 5.0; GraphPad Software, La Jolla, CA, USA). Exclusion of animals was not applied.
The primary PET outcome measure (V T ) was analyzed using multivariate general linear modeling using SPSS Statistics (Version 22.0, IBM). The V T values obtained from the MFG were modeled based on the relationship to between-subject factors, including cohort (patients, CONs) and TSPO genotype (C/C: high-affinity binder, C/T: mixed-affinity binder) as independent fixed factors. Hence, the PET imaging data were analyzed using a 2 × 2 (cohort (patients, CONs) × TSPO genotype (C/C, C/T)) analysis of variance to account for the expected genotype effect on TSPO binding. 70 Statistical significance was set at P o 0.05 for all analyses.
RESULTS
Lower prefrontal TSPO density in a mouse model relevant to schizophrenia We evaluated TSPO protein density in the mouse MIA model, which was previously shown to capture a multitude of brain and behavioral abnormalities relevant to schizophrenia. [46] [47] [48] [49] [50] Here we confirm that adult offspring exposed to MIA show behavioral abnormalities implicated in schizophrenia, namely, impaired PPI of the acoustic startle reflex 50 Figure 2) .
We used IP staining to visualize and measure TSPO levels in distinct brain areas relevant to schizophrenia, including the mPFC, CA and dentate gyrus regions (Figure 1d ). TSPO immunoreactivity was clearly present in various cell types, including cells displaying varying degrees of ramification and cells of the brain vasculature ( Figure 1c ). Prenatal immune activation decreased TSPO density in the mPFC but not in CA or dentate gyrus regions (Figure 1e ). The MIA-induced reduction in prefrontal TSPO density emerged in both males and females (Supplementary Figure 3) and was confirmed in two independent cohorts of offspring (Figures 1e and f). Prefrontal TSPO density correlated positively with PPI scores in offspring exposed to MIA but not in CON offspring (Figure 1g ). There was no correlation between TSPO density and social interaction scores (Figure 1h ). Cellular sources of lower prefrontal TSPO density in a mouse model relevant to schizophrenia Using the MIA model, we further performed triple IF staining to measure the intensity of TSPO co-localized with Iba1 + microglia, GFAP + astrocytes and Glut1 + vascular endothelial cells. 4,6-Diamidine-2-phenylindole dihydrochloride (DAPI) was used as nuclear counterstain in all IF preparations. Based on the preceding results (Figures 1e and f) , we focused the co-localization studies on prefrontal sections obtained from MIA-exposed and CON offspring.
We identified clear co-localization between TSPO and all cell types investigated (Figures 2a, c and e) . Hence, the analyses of IF-stained sections confirmed the impressions obtained from the initial IP staining, which suggested widespread TSPO protein expression in multiple CNS cell types (Figure 1c Prefrontal neuroimmune profiles in a mouse model relevant to schizophrenia The analyses of Iba1 + and GFAP + area fractions in IF-stained sections indicated that MIA did not cause overt microglial or astroglial anomalies in the mPFC (Figures 2b and d) . To further examine this hypothesis, we assessed Iba1, CD68 and GFAP immunoreactivity on IP-stained prefrontal sections. Unbiased stereological estimations of Iba1 + microglia showed that MIA did not alter the density (number of immunoreactive cells per mm 3 ) of total microglia in the mPFC (Figure 3a ). There were also no group differences with respect to cell soma area and primary branches of Iba1 + -positive cells (Figure 3a) , suggesting that activation-related morphology of prefrontal microglia was not changed by MIA. Consistent with previous investigations 51, 52 and with our analyses of IF-stained sections (Figures 2b and d) , there were also no group differences with regards to prefrontal CD68 (Figure 3b ) and GFAP (Figure 3c ) relative optical densities in the mPFC. MIA-exposed offspring displayed, however, significantly increased prefrontal protein levels of several inflammatory cytokines, including IL-1β, IL-5 and IL-6, and a trend towards elevated prefrontal interferon-γ protein (Figure 3d ). Contrary to the mPFC, plasma cytokines were either unchanged or decreased in MIA-exposed offspring relative to CONs (Supplementary Figure 4) . Our results thus show that MIA induces selective neuroimmune changes that are characterized by increased inflammatory cytokine expression in the absence of overt micro-/astroglial anomalies or signs of systemic inflammation.
TSPO ligand binding in patients with recent-onset schizophrenia
We aimed at translating the preclinical findings of altered prefrontal TSPO expression to the human clinical condition. To this end, we analyzed PET TSPO binding in the MFG of patients with recent-onset schizophrenia and matched CON subjects using the second-generation TSPO radiotracer, [ 11 C]DPA-713. Consistent with previous studies, 70, 78 high-affinity binders harboring the C/C TSPO genotype generally displayed higher V T values for [
11 C] DPA-713 compared with mixed-affinity binders with the C/T genotype (Figure 4a ). There was a strong trend towards reduced [ 11 C]DPA-713 binding in the MFG of patients with recent-onset schizophrenia relative to CON subjects independently of the TSPO genotype (Figure 4a ). Quantitative analysis of the magnetic resonance imaging-based segmentation of the MFG showed no significant evidence of changes in MFG volume in patients with recent onset of schizophrenia (39.19 ± 6.75 cm 3 ) compared with CONs (42.73 ± 4.06 cm 3 ). There was also no significant difference in intracranial volume between patients and CONs as previously reported. 41 We complemented the human in vivo PET imaging studies with ex vivo autoradiography experiments assessing TSPO ligand binding in the mPFC of MIA-exposed and CON offspring. There were no significant group differences in ex vivo Table 2 ).
Increased TSPO density in a mouse model of neurodegeneration and reactive gliosis In a last series of experiments, we explored TSPO expression in the KA mouse model of acute neurodegeneration and reactive gliosis. Consistent with previous findings, [54] [55] [56] [57] we found that intrahippocampal KA injection induced clear signs of reactive gliosis, as evident by the marked increases in microglial CD68 and astroglial Figures 5a and b) . Notably, these glial changes were accompanied by a robust increase in TSPO IP immunoreactivity (Figure 5c ). IF staining coupled with confocal laser scanning microscopy further demonstrated that the KA-induced increase in TSPO expression similarly emerged in CD68 + microglia (Figure 5d ), GFAP + astrocytes (Figure 5e ) and Glut1 + vascular endothelial cells (Figure 5f ). Together, these results show that multiple cells of the CNS increase TSPO expression in the event of acute neurodegeneration and reactive gliosis.
DISCUSSION
PET imaging using TSPO radiotracers has become a popular approach to assess central inflammatory abnormalities in schizophrenia and related neurodevelopmental disorders. [22] [23] [24] [25] These investigations have been largely motivated by findings showing increased TSPO binding occurring in response to pronounced inflammatory stimuli such as acute endotoxemia 31, 32 or in the event of neurodegeneration and reactive gliosis. [33] [34] [35] Using a mouse model of acute neurodegeneration induced by intrahippocampal KA injection, our study confirms that TSPO is markedly upregulated in the event of reactive gliosis. Such severe neuroinflammatory conditions, however, critically differ from the neuroimmune profiles of most neurodevelopmental disorders such as schizophrenia. [9] [10] [11] [12] [13] [14] To mimic the latter, we used a wellcharacterized mouse model that is based on MIA-induced neurodevelopmental disruption. [46] [47] [48] [49] [50] Consistent with previous findings, 50-52,61,62 adult mice exposed to POL-induced MIA displayed schizophrenia-relevant behavioral abnormalities and elevated prefrontal levels of inflammatory cytokines in the absence of overt glial anomalies. Although the precise sources of increased prefrontal cytokine expression remain elusive (Supplementary Discussion), the neuroimmune profile in the MIA model is reminiscent of cytokine-associated inflammatory abnormalities present in prefrontal areas of (a subset of) chronic patients with schizophrenia. 10, 11 Our findings challenge the widely accepted assumption that increased TSPO expression in schizophrenia generally mirrors central inflammation and altered microglia activity. 23, [36] [37] [38] [39] [40] First, the MIA-based neurodevelopmental disruption model shows that increased levels of inflammatory cytokines can emerge concomitantly with a downregulation (rather than upregulation) of TSPO. Second, the downregulation of prefrontal TSPO in the MIA model was not associated with overt signs of microglial anomalies nor was there an association between microglia morphology and TSPO expression in this neurodevelopmental animal model relevant to schizophrenia. Consistent with previous immunohistochemical studies in the rodent and human brain, 79, 80 we found that TSPO immunoreactivity was clearly present in various CNS cell types, including microglia, astrocytes and vascular endothelial cells. Moreover, the MIA and KA models both revealed altered TSPO levels in all these cell types. These findings thus emphasize that altered TSPO expression or ligand binding cannot be equated with altered microglia activity only, even in neuropathologies that involve severe microgliosis. Third, a strong trend towards reduced TSPO ligand binding was also observed in PET imaging of recentonset schizophrenia relative to CONs. It is important to point out that our cohort of patients and CONs were previously characterized in terms of inflammatory profiles at the time the PET scans were acquired. 41 These previous investigations confirmed a significant elevation of inflammatory cytokines in the cerebrospinal fluid and plasma of patients relative to CONs. 41 In this previous study, the interval between blood sample collection and the initiation of the PET scan was o1 h, 41 which allowed us to explore possible correlations between TSPO binding and cytokine levels in close temporal proximity. These latter analyses, however, did not reveal significant correlations between peripheral (or to be negative and is unlikely driven by sole changes in microglia activity.
A negative relationship between central low-grade inflammation and TSPO expression may be explained by the known antiinflammatory properties of TSPO. [81] [82] [83] [84] [85] In this regard, upregulation of TSPO may be an adaptive response mechanism that counteracts or limits acute inflammatory responses in the CNS, whereas a downregulation may facilitate chronic low-grade inflammatory processes. Under certain pathological conditions, however, changes in TSPO may not be primarily triggered by inflammatory factors such as cytokines, but rather by other pathophysiological mechanisms. Such alternative mechanism may include changes in cellular metabolism, mitochondrial dysfunctions and/ or oxidative stress, [86] [87] [88] [89] all of which have been implicated in schizophrenia 4, 90, 91 and disease-relevant animal models. [92] [93] [94] Whatever processes involved, our findings suggest that a downregulation of TSPO may have a pathological relevance for certain schizophrenia-related behavioral anomalies. In the MIA model, we revealed a positive correlation between TSPO levels in the mPFC and PPI scores, suggesting that a downregulation of prefrontal TSPO is associated with more severe sensorimotor gating impairments in animals with neurodevelopmental abnormalities. The precise relationship between prefrontal TSPO downregulation and sensorimotor gating impairments remains to be determined, but is in agreement with the known role of the mPFC in regulating sensorimotor gating and other neurocognitive processes. [95] [96] [97] [98] The correlation between prefrontal TSPO and PPI in the MIA model is in line with a recent second-generation TSPO PET imaging study, indicating that lower TSPO binding in gray matter is associated with more severe psychopathology (as assessed using the Positive and Negative Syndrome Scale) and worse neurocognitive performance (as assessed using the Repeatable Battery for the Assessment of Neuropsychological Status) in untreated first-episode psychosis patients. 42 Interestingly, however, there was no correlation between inflammationmediated impairments in social interaction and prefrontal TSPO levels, suggesting that the downregulation of prefrontal TSPO may be relevant only for a subset of schizophrenia-related behavioral dysfunctions.
Based on the findings obtained in the MIA model, our PET study focused on TSPO ligand binding in the MFG, which spans a substantial part of the human dorsolateral prefrontal cortex 71, 72 and is structurally and functionally related to the mPFC in rodents. 73, 74 Some early studies using the first-generation radiotracer [
11 C]PK11195 found increased TSPO binding in temporal regions of patients with schizophrenia relative to CONs. 36, 37 A number of more recent investigations, however, failed to replicate these findings, including studies using more selective secondgeneration TSPO radiotracers. [39] [40] [41] [42] [43] Importantly, a lack of increased (or even trends towards reduced) TSPO binding has been noted across various brain regions in antipsychotic naive, first-episode psychosis patients, 42, 43 as well as in recent-onset schizophrenia patients with confirmed inflammatory cytokine alterations. 41 The current hypothesis-driven TSPO PET imaging approach, which focused specifically on the MFG of patients with recent-onset schizophrenia, is consistent with these latter studies. One limitation of the present study is that in vivo PET imaging was performed using one single TSPO radiotracer only. To this end, we selected the second-generation radiotracer [
11 C]DPA-713, which shows an increased signal-to-noise ratio as compared with the prototypical first-generation radiotracer [
11 C]PK11195. 44, 45, 68 As various second-generation TSPO ligands are currently available, 44 our study cannot be considered comprehensive with respect to comparing multiple second-generation radiotracers. However, distinct second-generation TSPO radiotracers are largely identical in terms of their binding specificity and pharmacokinetics, 26, 99, 100 so that we would expect similar findings when using other second-generation TSPO ligands.
Thus far, only one study reported increased TSPO ligand binding using a second-generation radiotracer in patients with schizophrenia or subjects at ultra-high risk of psychosis. 38 In this study, Bloomfield et al. 38 found a small ( o 5%) but significant increase in TSPO binding ratios in total gray matter as well as in temporal and frontal lobes of affected individuals relative to matched CONs. This positive report, however, was not based on analysis of regional distribution volumes (V T ), but rather relied on distribution volume ratios as the primary outcome measure. The latter approach may complicate interpretations for PET radiotracer studies involving TSPO, which lack a true reference region. 75, 101 Interestingly, the direct comparison between ex vivo autoradiography and immunohistochemical techniques in the MIA model revealed inconsistent results with regards to prefrontal TSPO expression and binding. Whereas a TSPO downregulation was confirmed in two independent cohorts of MIA offspring using immunohistochemistry, ex vivo autoradiography with first-or second-generation TSPO ligands did not reveal such differences. Several previous studies assessed the extent to which ex vivo TSPO autoradiography correlates with in vivo PET imaging using firstgeneration ([ 11 C]PK11195) and second-generation (including [ 11 C] DPA-713) TSPO radiotracers in excitotoxicity-or autoimmuneinduced models of severe neuroinflammation. [102] [103] [104] These withinspecies studies revealed clear correlations between the ex vivo and in vivo approaches, at least when measured in the pathological context of severe reactive gliosis. [102] [103] [104] Given these correlations, we believe that the inconsistent findings obtained by TSPO immunohistochemistry and autoradiography in the MIA model are readily explainable by the lower resolution of ex vivo radiotracer assays as compared with immunohistochemical techniques, the latter of which can provide analyses at the cellular and subcellular resolution level. 105 Therefore, the latter technique is likely to be more suitable for detecting relatively small changes in TSPO expression in small organs such as the mouse brain, whereas in vivo TSPO PET imaging may still yield satisfactory results in larger organs such the human brain.
In conclusion, our study has a number of implications for current attempts to define neuroimmune profiles in schizophrenia and related disorders using the TSPO biomarker. First, reduced TSPO expression can occur concomitantly with signs of central low-grade inflammation. Hence, decreased TSPO expression does not (necessarily) suggest reduced inflammation (and vice versa), implying furthermore that ongoing inflammatory processes are not always mirrored by increased TSPO signals. Without the concomitant assessment of additional inflammatory markers such as cytokines, interpreting 'neuroinflammation' on the sole basis of TSPO signals can readily lead to wrong conclusions. Second, altered TSPO levels do not reflect selective changes in microglia activity, neither in (infection-mediated) neurodevelopmental pathologies nor in severe neuroinflammatory conditions that are accompanied by marked microgliosis. Our study thus underscores the need to interpret in vivo or ex vivo imaging signals using TSPO radiotracers with caution, especially when such readouts are not complemented with other measures of inflammatory processes. Unless more selective glial markers are available for PET imaging, quantification of cytokines and other inflammatory biomarkers, along with their molecular signaling pathways, 4, [8] [9] [10] [11] [12] [14] [15] [16] 41 may not only be more sensitive, but also more accurate, in attempts to characterize inflammatory profiles in schizophrenia and other mental disorders that lack robust reactive gliosis.
CONFLICT OF INTEREST
ACV has previously received grant support from F. Hoffmann-La Roche Ltd. The remaining authors declare no conflict of interest. The present work is purely academic.
ACKNOWLEDGMENTS
We thank Professor Jean-Marc Fritschy (Institute of Pharmacology and Toxicology, University of Zurich, Switzerland) for his technical assistance in the immunohistochemical procedures. We are also thankful to Dr Sandra Giovanoli for her assistance in behavioral experimentation and stereological analyses. This work was supported by the Swiss National Science Foundation (grant nos 310030_146217 and 310030_169544) and the Foundation for Research in Science and the Humanities at the University of Zurich awarded to UM. Additional financial support for this study was provided by NARSAD (awarded to JC and AS), the Alexander Wilson Schweizer Fellowship (awarded to JC), by a Silvio O. Conte Center grant (MH094268, awarded to AS) and by the Medical Research Council (New Investigator Grant, MR/N025377/1, awarded to ACV). 
AUTHOR CONTRIBUTIONS

